MedTech 领导者讨论 AI、网络安全和并购
Medtech leaders discuss AI, cybersecurity and M&A at AdvaMed’s The MedTech Conference
在 AdvaMed 的 The MedTech Conference 上,超过 4,000 名医疗科技行业领袖、监管者和创新者齐聚波士顿,讨论了人工智能、网络安全、并购、供应链和经济挑战等热点话题。医疗科技公司预计将进一步精简产品组合并进行小型并购,同时重新调整供应链以应对关税波动。食品和药物管理局的设备和放射健康中心负责人表示,医疗科技公司应关注生成式人工智能的指导方针。
An article from
More than 4,000 people across the medtech sector met in Boston for one of the industry’s biggest events of the year. Catch up on all the conference news in MedTech Dive’s roundup.
Published Oct. 23, 2026
At one of the largest medical device events of the year, attendees met to discuss the latest developments in a year marked by high-profile cyberattacks and questions about artificial intelligence regulations.
At AdvaMed’s The MedTech Conference, more than 4,000 company leaders, regulators and innovators met in Boston.
Hot topics included AI, cybersecurity, M&A, supply chain and a challenging economy. Medtech executives said to expect more portfolio trimming and tuck-in acquisitions as companies face limited resources. They also shared how they are retooling their supply chains amid on-and-off tariffs.
Meanwhile, device leaders with the Food and Drug Administration signaled that medtech firms should watch for guidance on generative AI, and shared an update on hiring for the Center for Devices and Radiological Health and other priorities.
Catch up on MedTech Dive’s coverage of the conference below:
来源:MedTech Dive 器械媒体 · medtechdive.com